Free Trial

Health In Tech (HIT) Competitors

Health In Tech logo
$1.06 0.00 (0.00%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$1.08 +0.02 (+1.89%)
As of 07:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HIT vs. KFS, NODK, OSG, KINS, and SLQT

Should you buy Health In Tech stock or one of its competitors? MarketBeat compares Health In Tech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health In Tech include Kingsway Financial Services (KFS), NI (NODK), Octave Specialty Group (OSG), Kingstone Companies (KINS), and SelectQuote (SLQT). These companies are all part of the "insurance" industry.

How does Health In Tech compare to Kingsway Financial Services?

Health In Tech (NASDAQ:HIT) and Kingsway Financial Services (NYSE:KFS) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Health In Tech has a net margin of 0.00% compared to Kingsway Financial Services' net margin of -8.83%. Health In Tech's return on equity of 0.00% beat Kingsway Financial Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
Kingsway Financial Services -8.83%-72.50%-5.67%

Health In Tech has a beta of 3.67, indicating that its share price is 267% more volatile than the broader market. Comparatively, Kingsway Financial Services has a beta of 0.27, indicating that its share price is 73% less volatile than the broader market.

72.4% of Kingsway Financial Services shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 41.4% of Kingsway Financial Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Health In Tech had 9 more articles in the media than Kingsway Financial Services. MarketBeat recorded 10 mentions for Health In Tech and 1 mentions for Kingsway Financial Services. Health In Tech's average media sentiment score of 0.74 beat Kingsway Financial Services' score of 0.32 indicating that Health In Tech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
0 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kingsway Financial Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Health In Tech has higher earnings, but lower revenue than Kingsway Financial Services. Health In Tech is trading at a lower price-to-earnings ratio than Kingsway Financial Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$34.08M1.86-$1.20M-$0.02N/A
Kingsway Financial Services$134.97M2.31-$10.73M-$0.40N/A

Health In Tech currently has a consensus price target of $3.25, indicating a potential upside of 206.60%. Given Health In Tech's stronger consensus rating and higher possible upside, equities research analysts clearly believe Health In Tech is more favorable than Kingsway Financial Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00
Kingsway Financial Services
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Health In Tech beats Kingsway Financial Services on 12 of the 16 factors compared between the two stocks.

How does Health In Tech compare to NI?

Health In Tech (NASDAQ:HIT) and NI (NASDAQ:NODK) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Health In Tech has a net margin of 0.00% compared to NI's net margin of -1.60%. Health In Tech's return on equity of 0.00% beat NI's return on equity.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
NI -1.60%-1.79%-0.81%

Health In Tech has a beta of 3.67, indicating that its share price is 267% more volatile than the broader market. Comparatively, NI has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

21.9% of NI shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 1.0% of NI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Health In Tech had 8 more articles in the media than NI. MarketBeat recorded 10 mentions for Health In Tech and 2 mentions for NI. NI's average media sentiment score of 1.25 beat Health In Tech's score of 0.74 indicating that NI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
0 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NI
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Health In Tech has higher earnings, but lower revenue than NI. NI is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$34.08M1.86-$1.20M-$0.02N/A
NI$285.05M0.99-$10.41M-$0.20N/A

Health In Tech currently has a consensus price target of $3.25, indicating a potential upside of 206.60%. Given Health In Tech's stronger consensus rating and higher possible upside, equities research analysts clearly believe Health In Tech is more favorable than NI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00
NI
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Health In Tech beats NI on 13 of the 16 factors compared between the two stocks.

How does Health In Tech compare to Octave Specialty Group?

Health In Tech (NASDAQ:HIT) and Octave Specialty Group (NYSE:OSG) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Health In Tech has higher earnings, but lower revenue than Octave Specialty Group. Health In Tech is trading at a lower price-to-earnings ratio than Octave Specialty Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$34.08M1.86-$1.20M-$0.02N/A
Octave Specialty Group$251.22M1.01-$261.69M-$4.86N/A

80.9% of Octave Specialty Group shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 7.2% of Octave Specialty Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Health In Tech has a beta of 3.67, indicating that its share price is 267% more volatile than the broader market. Comparatively, Octave Specialty Group has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market.

Health In Tech currently has a consensus price target of $3.25, indicating a potential upside of 206.60%. Octave Specialty Group has a consensus price target of $15.00, indicating a potential upside of 165.25%. Given Health In Tech's stronger consensus rating and higher possible upside, equities research analysts clearly believe Health In Tech is more favorable than Octave Specialty Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00
Octave Specialty Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Health In Tech has a net margin of 0.00% compared to Octave Specialty Group's net margin of -75.91%. Health In Tech's return on equity of 0.00% beat Octave Specialty Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
Octave Specialty Group -75.91%-0.55%-0.13%

In the previous week, Health In Tech had 5 more articles in the media than Octave Specialty Group. MarketBeat recorded 10 mentions for Health In Tech and 5 mentions for Octave Specialty Group. Health In Tech's average media sentiment score of 0.74 beat Octave Specialty Group's score of 0.66 indicating that Health In Tech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
0 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Octave Specialty Group
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Health In Tech beats Octave Specialty Group on 13 of the 17 factors compared between the two stocks.

How does Health In Tech compare to Kingstone Companies?

Health In Tech (NASDAQ:HIT) and Kingstone Companies (NASDAQ:KINS) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Health In Tech presently has a consensus price target of $3.25, indicating a potential upside of 206.60%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Kingstone Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00
Kingstone Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Health In Tech has a beta of 3.67, indicating that its stock price is 267% more volatile than the broader market. Comparatively, Kingstone Companies has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market.

Kingstone Companies has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than Kingstone Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$34.08M1.86-$1.20M-$0.02N/A
Kingstone Companies$214.87M0.99$40.77M$2.156.87

Kingstone Companies has a net margin of 13.86% compared to Health In Tech's net margin of 0.00%. Kingstone Companies' return on equity of 28.63% beat Health In Tech's return on equity.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
Kingstone Companies 13.86%28.63%7.23%

14.9% of Kingstone Companies shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by company insiders. Comparatively, 5.1% of Kingstone Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Health In Tech had 3 more articles in the media than Kingstone Companies. MarketBeat recorded 10 mentions for Health In Tech and 7 mentions for Kingstone Companies. Kingstone Companies' average media sentiment score of 1.17 beat Health In Tech's score of 0.74 indicating that Kingstone Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
0 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kingstone Companies
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Kingstone Companies beats Health In Tech on 9 of the 16 factors compared between the two stocks.

How does Health In Tech compare to SelectQuote?

Health In Tech (NASDAQ:HIT) and SelectQuote (NYSE:SLQT) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

Health In Tech currently has a consensus target price of $3.25, indicating a potential upside of 206.60%. SelectQuote has a consensus target price of $2.92, indicating a potential upside of 152.53%. Given Health In Tech's stronger consensus rating and higher probable upside, equities analysts plainly believe Health In Tech is more favorable than SelectQuote.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00
SelectQuote
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.60

Health In Tech has a beta of 3.67, meaning that its share price is 267% more volatile than the broader market. Comparatively, SelectQuote has a beta of 1.62, meaning that its share price is 62% more volatile than the broader market.

SelectQuote has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than SelectQuote, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$34.08M1.86-$1.20M-$0.02N/A
SelectQuote$1.53B0.13$47.58M$0.0912.83

SelectQuote has a net margin of 5.60% compared to Health In Tech's net margin of 0.00%. SelectQuote's return on equity of 20.49% beat Health In Tech's return on equity.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
SelectQuote 5.60%20.49%5.58%

34.6% of SelectQuote shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 13.1% of SelectQuote shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Health In Tech had 8 more articles in the media than SelectQuote. MarketBeat recorded 10 mentions for Health In Tech and 2 mentions for SelectQuote. Health In Tech's average media sentiment score of 0.74 beat SelectQuote's score of 0.60 indicating that Health In Tech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
0 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SelectQuote
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

SelectQuote beats Health In Tech on 8 of the 15 factors compared between the two stocks.

Get Health In Tech News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIT vs. The Competition

MetricHealth In TechInsurance Agents, Brokers & Service IndustryFinance SectorNASDAQ Exchange
Market Cap$63.56M$20.39B$13.36B$12.29B
Dividend YieldN/A2.24%5.87%5.30%
P/E Ratio-53.0041.1823.5325.26
Price / Sales1.867.26166.8573.54
Price / CashN/A38.4619.9137.27
Price / BookN/A2.992.176.71
Net Income-$1.20M$1.40B$1.13B$336.00M
7 Day Performance-28.38%-8.56%-1.07%-0.72%
1 Month Performance-29.33%-9.58%-1.31%-0.09%
1 Year Performance70.61%19.29%9.14%30.62%

Health In Tech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIT
Health In Tech
2.1868 of 5 stars
$1.06
flat
$3.25
+206.6%
+70.6%$63.56M$34.08MN/A79
KFS
Kingsway Financial Services
0.2977 of 5 stars
$11.75
+9.8%
N/A+4.3%$341.58M$147.33MN/A280
NODK
NI
0.4505 of 5 stars
$12.81
-0.9%
N/A+8.7%$262.87M$285.05MN/A210
OSG
Octave Specialty Group
4.1839 of 5 stars
$5.36
-11.5%
$15.00
+180.1%
N/A$241.73M$251.22MN/A130
KINS
Kingstone Companies
4.2576 of 5 stars
$15.51
-4.0%
N/A-14.8%$224.54M$214.87M7.2190

Related Companies and Tools


This page (NASDAQ:HIT) was last updated on 5/18/2026 by MarketBeat.com Staff.
From Our Partners